Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:( methotrexate). Showing records 1 – 30 of 147 total matches.

[1] [2] [3] [4] [5]

Search Limiters

Last 2 Years | English Only

Levels

Languages

Country

▼ Search Limiters


University of Manchester

1. Owen, Sally-Anne. Genetic predictors of response to methotrexate in patients with rheumatoid arthritis.

Degree: 2012, University of Manchester

 Abstract The University of Manchester, Sally-Anne Owen, PhD, Genetic predictors of response to methotrexate in patients with rheumatoid arthritis, 2012.Background: Methotrexate (MTX) is the cornerstone… (more)

Subjects/Keywords: Methotrexate; Genetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Owen, S. (2012). Genetic predictors of response to methotrexate in patients with rheumatoid arthritis. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:163482

Chicago Manual of Style (16th Edition):

Owen, Sally-Anne. “Genetic predictors of response to methotrexate in patients with rheumatoid arthritis.” 2012. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:163482.

MLA Handbook (7th Edition):

Owen, Sally-Anne. “Genetic predictors of response to methotrexate in patients with rheumatoid arthritis.” 2012. Web. 07 Aug 2020.

Vancouver:

Owen S. Genetic predictors of response to methotrexate in patients with rheumatoid arthritis. [Internet] [Doctoral dissertation]. University of Manchester; 2012. [cited 2020 Aug 07]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:163482.

Council of Science Editors:

Owen S. Genetic predictors of response to methotrexate in patients with rheumatoid arthritis. [Doctoral Dissertation]. University of Manchester; 2012. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:163482


University of Manchester

2. Owen, Sally-Anne. Genetic predictors of response to methotrexate in patients with rheumatoid arthritis.

Degree: PhD, 2013, University of Manchester

 Background: Methotrexate (MTX) is the cornerstone of treatment for inflammatory arthritis. However inadequate response occurs in approximately 30% of patients treated. The main determinants of… (more)

Subjects/Keywords: Genetics; Methotrexate

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Owen, S. (2013). Genetic predictors of response to methotrexate in patients with rheumatoid arthritis. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/genetic-predictors-of-response-to-methotrexate-in-patients-with-rheumatoid-arthritis(18ee1ccb-3b69-45e3-8104-087bb5afefb2).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771289

Chicago Manual of Style (16th Edition):

Owen, Sally-Anne. “Genetic predictors of response to methotrexate in patients with rheumatoid arthritis.” 2013. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. https://www.research.manchester.ac.uk/portal/en/theses/genetic-predictors-of-response-to-methotrexate-in-patients-with-rheumatoid-arthritis(18ee1ccb-3b69-45e3-8104-087bb5afefb2).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771289.

MLA Handbook (7th Edition):

Owen, Sally-Anne. “Genetic predictors of response to methotrexate in patients with rheumatoid arthritis.” 2013. Web. 07 Aug 2020.

Vancouver:

Owen S. Genetic predictors of response to methotrexate in patients with rheumatoid arthritis. [Internet] [Doctoral dissertation]. University of Manchester; 2013. [cited 2020 Aug 07]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/genetic-predictors-of-response-to-methotrexate-in-patients-with-rheumatoid-arthritis(18ee1ccb-3b69-45e3-8104-087bb5afefb2).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771289.

Council of Science Editors:

Owen S. Genetic predictors of response to methotrexate in patients with rheumatoid arthritis. [Doctoral Dissertation]. University of Manchester; 2013. Available from: https://www.research.manchester.ac.uk/portal/en/theses/genetic-predictors-of-response-to-methotrexate-in-patients-with-rheumatoid-arthritis(18ee1ccb-3b69-45e3-8104-087bb5afefb2).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771289

3. O'FARRELL, LAURA. The Effects of Low-Dose Methotrexate on Metabolism in Primary Human PBMCs.

Degree: School of Biochemistry & Immunology. Discipline of Biochemistry, 2017, Trinity College Dublin

 Low-dose Methotrexate (MTX) is a powerful anti-arthritic drug used in the treatment of a variety of inflammatory diseases. It is an economical drug and is… (more)

Subjects/Keywords: PBMC; Methotrexate; Metabolism

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

O'FARRELL, L. (2017). The Effects of Low-Dose Methotrexate on Metabolism in Primary Human PBMCs. (Thesis). Trinity College Dublin. Retrieved from http://hdl.handle.net/2262/82002

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

O'FARRELL, LAURA. “The Effects of Low-Dose Methotrexate on Metabolism in Primary Human PBMCs.” 2017. Thesis, Trinity College Dublin. Accessed August 07, 2020. http://hdl.handle.net/2262/82002.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

O'FARRELL, LAURA. “The Effects of Low-Dose Methotrexate on Metabolism in Primary Human PBMCs.” 2017. Web. 07 Aug 2020.

Vancouver:

O'FARRELL L. The Effects of Low-Dose Methotrexate on Metabolism in Primary Human PBMCs. [Internet] [Thesis]. Trinity College Dublin; 2017. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2262/82002.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

O'FARRELL L. The Effects of Low-Dose Methotrexate on Metabolism in Primary Human PBMCs. [Thesis]. Trinity College Dublin; 2017. Available from: http://hdl.handle.net/2262/82002

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Pretoria

4. Visser, Suzaan. The toxicity and therapeutic index of a methotrexate polymeric compound, D-85.

Degree: Pharmacology, 2008, University of Pretoria

Methotrexate (MTX) has been used for many years in the treatment of patients with cancer as a cytotoxic agent and as an anti-inflammatory drug for… (more)

Subjects/Keywords: Cytotoxic; Methotrexate; Cancer; UCTD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Visser, S. (2008). The toxicity and therapeutic index of a methotrexate polymeric compound, D-85. (Doctoral Dissertation). University of Pretoria. Retrieved from http://hdl.handle.net/2263/24575

Chicago Manual of Style (16th Edition):

Visser, Suzaan. “The toxicity and therapeutic index of a methotrexate polymeric compound, D-85.” 2008. Doctoral Dissertation, University of Pretoria. Accessed August 07, 2020. http://hdl.handle.net/2263/24575.

MLA Handbook (7th Edition):

Visser, Suzaan. “The toxicity and therapeutic index of a methotrexate polymeric compound, D-85.” 2008. Web. 07 Aug 2020.

Vancouver:

Visser S. The toxicity and therapeutic index of a methotrexate polymeric compound, D-85. [Internet] [Doctoral dissertation]. University of Pretoria; 2008. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2263/24575.

Council of Science Editors:

Visser S. The toxicity and therapeutic index of a methotrexate polymeric compound, D-85. [Doctoral Dissertation]. University of Pretoria; 2008. Available from: http://hdl.handle.net/2263/24575


University of Pretoria

5. [No author]. The toxicity and therapeutic index of a methotrexate polymeric compound, D-85 .

Degree: 2008, University of Pretoria

Methotrexate (MTX) has been used for many years in the treatment of patients with cancer as a cytotoxic agent and as an anti-inflammatory drug for… (more)

Subjects/Keywords: Cytotoxic; Methotrexate; Cancer; UCTD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

author], [. (2008). The toxicity and therapeutic index of a methotrexate polymeric compound, D-85 . (Doctoral Dissertation). University of Pretoria. Retrieved from http://upetd.up.ac.za/thesis/available/etd-05122008-133405/

Chicago Manual of Style (16th Edition):

author], [No. “The toxicity and therapeutic index of a methotrexate polymeric compound, D-85 .” 2008. Doctoral Dissertation, University of Pretoria. Accessed August 07, 2020. http://upetd.up.ac.za/thesis/available/etd-05122008-133405/.

MLA Handbook (7th Edition):

author], [No. “The toxicity and therapeutic index of a methotrexate polymeric compound, D-85 .” 2008. Web. 07 Aug 2020.

Vancouver:

author] [. The toxicity and therapeutic index of a methotrexate polymeric compound, D-85 . [Internet] [Doctoral dissertation]. University of Pretoria; 2008. [cited 2020 Aug 07]. Available from: http://upetd.up.ac.za/thesis/available/etd-05122008-133405/.

Council of Science Editors:

author] [. The toxicity and therapeutic index of a methotrexate polymeric compound, D-85 . [Doctoral Dissertation]. University of Pretoria; 2008. Available from: http://upetd.up.ac.za/thesis/available/etd-05122008-133405/


University of Manchester

6. Bluett, James. Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis.

Degree: 2016, University of Manchester

 IntroductionRheumatoid arthritis (RA) is a multisystem disease associated with early mortality. Methotrexate (MTX) is the first-line therapy in RA but is associated with significant adverse… (more)

Subjects/Keywords: Rheumatoid arthritis; Adherence; Methotrexate; Pneumonitis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bluett, J. (2016). Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:296014

Chicago Manual of Style (16th Edition):

Bluett, James. “Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis.” 2016. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:296014.

MLA Handbook (7th Edition):

Bluett, James. “Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis.” 2016. Web. 07 Aug 2020.

Vancouver:

Bluett J. Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis. [Internet] [Doctoral dissertation]. University of Manchester; 2016. [cited 2020 Aug 07]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:296014.

Council of Science Editors:

Bluett J. Developing and Investigating Response Markers to Methotrexate in Rheumatoid Arthritis. [Doctoral Dissertation]. University of Manchester; 2016. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:296014

7. Bulgarelli, Adriana. Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose.

Degree: PhD, Análises Clínicas, 2010, University of São Paulo

 O Metotrexato (MTX) é um fármaco utilizado como anti-inflamatório no tratamento da artrite reumatóide (AR). O risco de doença cardiovascular em pacientes com AR é… (more)

Subjects/Keywords: Aterosclerose; Atherosclerosis; LDE; Methotrexate; Metotrexato; Nanopartícula

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bulgarelli, A. (2010). Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/9/9136/tde-24052010-162400/ ;

Chicago Manual of Style (16th Edition):

Bulgarelli, Adriana. “Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose.” 2010. Doctoral Dissertation, University of São Paulo. Accessed August 07, 2020. http://www.teses.usp.br/teses/disponiveis/9/9136/tde-24052010-162400/ ;.

MLA Handbook (7th Edition):

Bulgarelli, Adriana. “Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose.” 2010. Web. 07 Aug 2020.

Vancouver:

Bulgarelli A. Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose. [Internet] [Doctoral dissertation]. University of São Paulo; 2010. [cited 2020 Aug 07]. Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-24052010-162400/ ;.

Council of Science Editors:

Bulgarelli A. Uso de metotrexato associado à nanopartícula rica em colesterol (LDE) para tratamento da aterosclerose. [Doctoral Dissertation]. University of São Paulo; 2010. Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-24052010-162400/ ;


University of Cincinnati

8. Pinchasik, Dawn. Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy.

Degree: MS, Medicine: Clinical and Translational Research, 2013, University of Cincinnati

 BACKGROUND: Osteosarcoma is the most common primary malignancy of bone in children and adults. High-dose Methotrexate (MTX) is an important component of osteosarcoma therapy, but… (more)

Subjects/Keywords: Oncology; Osteosarcoma; methotrexate; osteosarcoma therapy; toxicity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pinchasik, D. (2013). Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy. (Masters Thesis). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377870526

Chicago Manual of Style (16th Edition):

Pinchasik, Dawn. “Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy.” 2013. Masters Thesis, University of Cincinnati. Accessed August 07, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377870526.

MLA Handbook (7th Edition):

Pinchasik, Dawn. “Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy.” 2013. Web. 07 Aug 2020.

Vancouver:

Pinchasik D. Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy. [Internet] [Masters thesis]. University of Cincinnati; 2013. [cited 2020 Aug 07]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377870526.

Council of Science Editors:

Pinchasik D. Predictors of and variability in methotrexate clearance among osteosarcoma patients receiving high-dose therapy. [Masters Thesis]. University of Cincinnati; 2013. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377870526

9. Gouveia, Viviane de Araújo. Impacto do metotrexato na reestenose após implante de stent coronariano convencional .

Degree: 2015, Universidade Federal de Pernambuco

 Introdução: O advento dos stents convencionais e daqueles liberadores de fármacos aboliu o recolhimento elástico provocado pela angioplastia por balão, porém, estes dispositivos apresentaram como… (more)

Subjects/Keywords: Reestenose; Metotrexato; Angioplastia; Restenosis; Methotrexate; Angioplasty

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gouveia, V. d. A. (2015). Impacto do metotrexato na reestenose após implante de stent coronariano convencional . (Thesis). Universidade Federal de Pernambuco. Retrieved from http://repositorio.ufpe.br/handle/123456789/16384

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gouveia, Viviane de Araújo. “Impacto do metotrexato na reestenose após implante de stent coronariano convencional .” 2015. Thesis, Universidade Federal de Pernambuco. Accessed August 07, 2020. http://repositorio.ufpe.br/handle/123456789/16384.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gouveia, Viviane de Araújo. “Impacto do metotrexato na reestenose após implante de stent coronariano convencional .” 2015. Web. 07 Aug 2020.

Vancouver:

Gouveia VdA. Impacto do metotrexato na reestenose após implante de stent coronariano convencional . [Internet] [Thesis]. Universidade Federal de Pernambuco; 2015. [cited 2020 Aug 07]. Available from: http://repositorio.ufpe.br/handle/123456789/16384.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gouveia VdA. Impacto do metotrexato na reestenose após implante de stent coronariano convencional . [Thesis]. Universidade Federal de Pernambuco; 2015. Available from: http://repositorio.ufpe.br/handle/123456789/16384

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Aberdeen

10. Almalag, Haya. Methotrexate and cardiovascular risk factors with a focus on arterial stiffness and blood pressure in patients with rheumatoid arthritis in Saudi Arabia : cross sectional and longitudinal analysis.

Degree: PhD, 2015, University of Aberdeen

 Background: Rheumatoid arthritis (RA) is an inflammatory disease associated with an increased risk of cardiovascular morbidity and mortality. Methotrexate is a widely used RA medication… (more)

Subjects/Keywords: 610; Methotrexate; Cardiovascular system; Hypertension; Rheumatoid arthritis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Almalag, H. (2015). Methotrexate and cardiovascular risk factors with a focus on arterial stiffness and blood pressure in patients with rheumatoid arthritis in Saudi Arabia : cross sectional and longitudinal analysis. (Doctoral Dissertation). University of Aberdeen. Retrieved from http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=228050 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.675578

Chicago Manual of Style (16th Edition):

Almalag, Haya. “Methotrexate and cardiovascular risk factors with a focus on arterial stiffness and blood pressure in patients with rheumatoid arthritis in Saudi Arabia : cross sectional and longitudinal analysis.” 2015. Doctoral Dissertation, University of Aberdeen. Accessed August 07, 2020. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=228050 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.675578.

MLA Handbook (7th Edition):

Almalag, Haya. “Methotrexate and cardiovascular risk factors with a focus on arterial stiffness and blood pressure in patients with rheumatoid arthritis in Saudi Arabia : cross sectional and longitudinal analysis.” 2015. Web. 07 Aug 2020.

Vancouver:

Almalag H. Methotrexate and cardiovascular risk factors with a focus on arterial stiffness and blood pressure in patients with rheumatoid arthritis in Saudi Arabia : cross sectional and longitudinal analysis. [Internet] [Doctoral dissertation]. University of Aberdeen; 2015. [cited 2020 Aug 07]. Available from: http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=228050 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.675578.

Council of Science Editors:

Almalag H. Methotrexate and cardiovascular risk factors with a focus on arterial stiffness and blood pressure in patients with rheumatoid arthritis in Saudi Arabia : cross sectional and longitudinal analysis. [Doctoral Dissertation]. University of Aberdeen; 2015. Available from: http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=228050 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.675578


University of Manchester

11. Rungapiromnan, Watcharee. Examining multimorbidity in patients with psoriasis and the impact of biologic therapies on the risk of major cardiovascular events.

Degree: PhD, 2018, University of Manchester

 Aims: The aims of this thesis were to examine the prevalence of physical and mental health comorbidities in patients with psoriasis and then subsequently examine… (more)

Subjects/Keywords: Methotrexate; Cardiovascular events; Biologic therapy; Psoriasis; Comorbidity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rungapiromnan, W. (2018). Examining multimorbidity in patients with psoriasis and the impact of biologic therapies on the risk of major cardiovascular events. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/examining-multimorbidity-in-patients-with-psoriasis-and-the-impact-of-biologic-therapies-on-the-risk-of-major-cardiovascular-events(6096c4b1-89ee-4dc1-b3c2-4878129b2c07).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.799274

Chicago Manual of Style (16th Edition):

Rungapiromnan, Watcharee. “Examining multimorbidity in patients with psoriasis and the impact of biologic therapies on the risk of major cardiovascular events.” 2018. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. https://www.research.manchester.ac.uk/portal/en/theses/examining-multimorbidity-in-patients-with-psoriasis-and-the-impact-of-biologic-therapies-on-the-risk-of-major-cardiovascular-events(6096c4b1-89ee-4dc1-b3c2-4878129b2c07).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.799274.

MLA Handbook (7th Edition):

Rungapiromnan, Watcharee. “Examining multimorbidity in patients with psoriasis and the impact of biologic therapies on the risk of major cardiovascular events.” 2018. Web. 07 Aug 2020.

Vancouver:

Rungapiromnan W. Examining multimorbidity in patients with psoriasis and the impact of biologic therapies on the risk of major cardiovascular events. [Internet] [Doctoral dissertation]. University of Manchester; 2018. [cited 2020 Aug 07]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/examining-multimorbidity-in-patients-with-psoriasis-and-the-impact-of-biologic-therapies-on-the-risk-of-major-cardiovascular-events(6096c4b1-89ee-4dc1-b3c2-4878129b2c07).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.799274.

Council of Science Editors:

Rungapiromnan W. Examining multimorbidity in patients with psoriasis and the impact of biologic therapies on the risk of major cardiovascular events. [Doctoral Dissertation]. University of Manchester; 2018. Available from: https://www.research.manchester.ac.uk/portal/en/theses/examining-multimorbidity-in-patients-with-psoriasis-and-the-impact-of-biologic-therapies-on-the-risk-of-major-cardiovascular-events(6096c4b1-89ee-4dc1-b3c2-4878129b2c07).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.799274


University of Manchester

12. Bluett, James A. Developing and investigating response markers to methotrexate in rheumatoid arthritis.

Degree: PhD, 2016, University of Manchester

 Introduction: Rheumatoid arthritis (RA) is a multisystem disease associated with early mortality. Methotrexate (MTX) is the first-line therapy in RA but is associated with significant… (more)

Subjects/Keywords: 616.7; Rheumatoid arthritis; Adherence; Methotrexate; Pneumonitis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bluett, J. A. (2016). Developing and investigating response markers to methotrexate in rheumatoid arthritis. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/developing-and-investigating-response-markers-to-methotrexate-in-rheumatoid-arthritis(3e6f6c3b-49ca-4502-be64-884e49a69e4b).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.734228

Chicago Manual of Style (16th Edition):

Bluett, James A. “Developing and investigating response markers to methotrexate in rheumatoid arthritis.” 2016. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. https://www.research.manchester.ac.uk/portal/en/theses/developing-and-investigating-response-markers-to-methotrexate-in-rheumatoid-arthritis(3e6f6c3b-49ca-4502-be64-884e49a69e4b).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.734228.

MLA Handbook (7th Edition):

Bluett, James A. “Developing and investigating response markers to methotrexate in rheumatoid arthritis.” 2016. Web. 07 Aug 2020.

Vancouver:

Bluett JA. Developing and investigating response markers to methotrexate in rheumatoid arthritis. [Internet] [Doctoral dissertation]. University of Manchester; 2016. [cited 2020 Aug 07]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/developing-and-investigating-response-markers-to-methotrexate-in-rheumatoid-arthritis(3e6f6c3b-49ca-4502-be64-884e49a69e4b).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.734228.

Council of Science Editors:

Bluett JA. Developing and investigating response markers to methotrexate in rheumatoid arthritis. [Doctoral Dissertation]. University of Manchester; 2016. Available from: https://www.research.manchester.ac.uk/portal/en/theses/developing-and-investigating-response-markers-to-methotrexate-in-rheumatoid-arthritis(3e6f6c3b-49ca-4502-be64-884e49a69e4b).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.734228


University of Manchester

13. Rungapiromnan, Watcharee. Examining Multimorbidity in Patients with Psoriasis and the Impact of Biologic Therapies on the Risk of Major Cardiovascular Events.

Degree: 2018, University of Manchester

 Aims: The aims of this thesis were to examine the prevalence of physical and mental health comorbidities in patients with psoriasis and then subsequently examine… (more)

Subjects/Keywords: Psoriasis; Comorbidity; Biologic therapy; Cardiovascular events; Methotrexate

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rungapiromnan, W. (2018). Examining Multimorbidity in Patients with Psoriasis and the Impact of Biologic Therapies on the Risk of Major Cardiovascular Events. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:317373

Chicago Manual of Style (16th Edition):

Rungapiromnan, Watcharee. “Examining Multimorbidity in Patients with Psoriasis and the Impact of Biologic Therapies on the Risk of Major Cardiovascular Events.” 2018. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:317373.

MLA Handbook (7th Edition):

Rungapiromnan, Watcharee. “Examining Multimorbidity in Patients with Psoriasis and the Impact of Biologic Therapies on the Risk of Major Cardiovascular Events.” 2018. Web. 07 Aug 2020.

Vancouver:

Rungapiromnan W. Examining Multimorbidity in Patients with Psoriasis and the Impact of Biologic Therapies on the Risk of Major Cardiovascular Events. [Internet] [Doctoral dissertation]. University of Manchester; 2018. [cited 2020 Aug 07]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:317373.

Council of Science Editors:

Rungapiromnan W. Examining Multimorbidity in Patients with Psoriasis and the Impact of Biologic Therapies on the Risk of Major Cardiovascular Events. [Doctoral Dissertation]. University of Manchester; 2018. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:317373


Universidad de Extremadura

14. González de Murillo Godoy, Silvia. Influencia de los polimorfismos genéticos en la respuesta terapéutica a metotrexato de pacientes con neoplasias hematológicas .

Degree: 2018, Universidad de Extremadura

 El metrotexato (MTX) constituye la piedra angular de los protocolos para el tratamiento de la Leucemia Aguda Linfoblástica (LAL), la neoplasia infantil más frecuente. A… (more)

Subjects/Keywords: Metotrexato; Leucemia; Polimorfismos; Methotrexate; Leukemia; Polymorphisms

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

González de Murillo Godoy, S. (2018). Influencia de los polimorfismos genéticos en la respuesta terapéutica a metotrexato de pacientes con neoplasias hematológicas . (Thesis). Universidad de Extremadura. Retrieved from http://hdl.handle.net/10662/7630

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

González de Murillo Godoy, Silvia. “Influencia de los polimorfismos genéticos en la respuesta terapéutica a metotrexato de pacientes con neoplasias hematológicas .” 2018. Thesis, Universidad de Extremadura. Accessed August 07, 2020. http://hdl.handle.net/10662/7630.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

González de Murillo Godoy, Silvia. “Influencia de los polimorfismos genéticos en la respuesta terapéutica a metotrexato de pacientes con neoplasias hematológicas .” 2018. Web. 07 Aug 2020.

Vancouver:

González de Murillo Godoy S. Influencia de los polimorfismos genéticos en la respuesta terapéutica a metotrexato de pacientes con neoplasias hematológicas . [Internet] [Thesis]. Universidad de Extremadura; 2018. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10662/7630.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

González de Murillo Godoy S. Influencia de los polimorfismos genéticos en la respuesta terapéutica a metotrexato de pacientes con neoplasias hematológicas . [Thesis]. Universidad de Extremadura; 2018. Available from: http://hdl.handle.net/10662/7630

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Bradford

15. Elbakay, Jamal Ali Mohamed. Synthesis and pharmacological evaluation of novel anti-tumour prodrugs : synthesis and pharmacological investigations into novel MMP-activated peptide-based prodrugs of methotrexate as potential cancer therapeutics.

Degree: PhD, 2017, University of Bradford

Methotrexate (MTX) is an antimetabolite anticancer agent that is used in treatment of multiple cancers, such as acute lymphoblastic leukaemia and osteosarcoma. A lack of… (more)

Subjects/Keywords: 616.99; Cancer; Prodrug; Methotrexate; HDMTX; Matrix Metalloproteinase (MMP); Peptide; Anticancer agents; Methotrexate (MTX)

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Elbakay, J. A. M. (2017). Synthesis and pharmacological evaluation of novel anti-tumour prodrugs : synthesis and pharmacological investigations into novel MMP-activated peptide-based prodrugs of methotrexate as potential cancer therapeutics. (Doctoral Dissertation). University of Bradford. Retrieved from http://hdl.handle.net/10454/15102

Chicago Manual of Style (16th Edition):

Elbakay, Jamal Ali Mohamed. “Synthesis and pharmacological evaluation of novel anti-tumour prodrugs : synthesis and pharmacological investigations into novel MMP-activated peptide-based prodrugs of methotrexate as potential cancer therapeutics.” 2017. Doctoral Dissertation, University of Bradford. Accessed August 07, 2020. http://hdl.handle.net/10454/15102.

MLA Handbook (7th Edition):

Elbakay, Jamal Ali Mohamed. “Synthesis and pharmacological evaluation of novel anti-tumour prodrugs : synthesis and pharmacological investigations into novel MMP-activated peptide-based prodrugs of methotrexate as potential cancer therapeutics.” 2017. Web. 07 Aug 2020.

Vancouver:

Elbakay JAM. Synthesis and pharmacological evaluation of novel anti-tumour prodrugs : synthesis and pharmacological investigations into novel MMP-activated peptide-based prodrugs of methotrexate as potential cancer therapeutics. [Internet] [Doctoral dissertation]. University of Bradford; 2017. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10454/15102.

Council of Science Editors:

Elbakay JAM. Synthesis and pharmacological evaluation of novel anti-tumour prodrugs : synthesis and pharmacological investigations into novel MMP-activated peptide-based prodrugs of methotrexate as potential cancer therapeutics. [Doctoral Dissertation]. University of Bradford; 2017. Available from: http://hdl.handle.net/10454/15102

16. KURATA, Tomohiko. Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3 : 腎側低膜のヒト有機アニオントランスポーターhOAT3によるペメトレキセドの輸送特性.

Degree: 博士(医学), 2017, Mie University / 三重大学

Purpose: Pemetrexed transport by human organic anion transporters, hOAT1 (SLC22A6) and hOAT3 (SLC22A8), were characterized in comparison with methotrexate. Methods: Accumulation of pemetrexed and methotrexate(more)

Subjects/Keywords: pemetrexed; organic anion transporter; methotrexate; renal tubular secretion; drug interaction

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

KURATA, T. (2017). Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3 : 腎側低膜のヒト有機アニオントランスポーターhOAT3によるペメトレキセドの輸送特性. (Thesis). Mie University / 三重大学. Retrieved from http://hdl.handle.net/10076/00016982

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

KURATA, Tomohiko. “Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3 : 腎側低膜のヒト有機アニオントランスポーターhOAT3によるペメトレキセドの輸送特性.” 2017. Thesis, Mie University / 三重大学. Accessed August 07, 2020. http://hdl.handle.net/10076/00016982.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

KURATA, Tomohiko. “Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3 : 腎側低膜のヒト有機アニオントランスポーターhOAT3によるペメトレキセドの輸送特性.” 2017. Web. 07 Aug 2020.

Vancouver:

KURATA T. Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3 : 腎側低膜のヒト有機アニオントランスポーターhOAT3によるペメトレキセドの輸送特性. [Internet] [Thesis]. Mie University / 三重大学; 2017. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10076/00016982.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

KURATA T. Characteristics of Pemetrexed Transport by Renal Basolateral Organic Anion Transporter hOAT3 : 腎側低膜のヒト有機アニオントランスポーターhOAT3によるペメトレキセドの輸送特性. [Thesis]. Mie University / 三重大学; 2017. Available from: http://hdl.handle.net/10076/00016982

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of California – San Diego

17. Beck, Sungjun. Mechanism of Action of Methotrexate Against Zika Virus.

Degree: Biology, 2018, University of California – San Diego

 Zika Virus (ZIKV), which is associated with microcephaly and Guillain-Barré syndrome, brought a serious public health impact to most of Latin America countries in 2015… (more)

Subjects/Keywords: Biology; Dihydrofolate reductase; High throughput screening; Methotrexate; Zika virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Beck, S. (2018). Mechanism of Action of Methotrexate Against Zika Virus. (Thesis). University of California – San Diego. Retrieved from http://www.escholarship.org/uc/item/4ch0p661

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Beck, Sungjun. “Mechanism of Action of Methotrexate Against Zika Virus.” 2018. Thesis, University of California – San Diego. Accessed August 07, 2020. http://www.escholarship.org/uc/item/4ch0p661.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Beck, Sungjun. “Mechanism of Action of Methotrexate Against Zika Virus.” 2018. Web. 07 Aug 2020.

Vancouver:

Beck S. Mechanism of Action of Methotrexate Against Zika Virus. [Internet] [Thesis]. University of California – San Diego; 2018. [cited 2020 Aug 07]. Available from: http://www.escholarship.org/uc/item/4ch0p661.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Beck S. Mechanism of Action of Methotrexate Against Zika Virus. [Thesis]. University of California – San Diego; 2018. Available from: http://www.escholarship.org/uc/item/4ch0p661

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Temple University

18. Wang, Zhan. IMPACT OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2/ABCC2) AND 3 (MRP3/ABCC3) ON THE PHARMACOKINETICS OF METHOTREXATE.

Degree: PhD, 2012, Temple University

Pharmaceutical Sciences

This dissertation presents an investigation of the impact of Multidrug Resistance-associated Protein 2/ATP-binding cassette superfamily C member 2 (Mrp2/Abcc2) and 3 (Mrp3/Abcc3) on… (more)

Subjects/Keywords: Pharmaceutical sciences; ABC transporters; Dose-dependent disposition; Methotrexate; Pharmacokinetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wang, Z. (2012). IMPACT OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2/ABCC2) AND 3 (MRP3/ABCC3) ON THE PHARMACOKINETICS OF METHOTREXATE. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,179025

Chicago Manual of Style (16th Edition):

Wang, Zhan. “IMPACT OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2/ABCC2) AND 3 (MRP3/ABCC3) ON THE PHARMACOKINETICS OF METHOTREXATE.” 2012. Doctoral Dissertation, Temple University. Accessed August 07, 2020. http://digital.library.temple.edu/u?/p245801coll10,179025.

MLA Handbook (7th Edition):

Wang, Zhan. “IMPACT OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2/ABCC2) AND 3 (MRP3/ABCC3) ON THE PHARMACOKINETICS OF METHOTREXATE.” 2012. Web. 07 Aug 2020.

Vancouver:

Wang Z. IMPACT OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2/ABCC2) AND 3 (MRP3/ABCC3) ON THE PHARMACOKINETICS OF METHOTREXATE. [Internet] [Doctoral dissertation]. Temple University; 2012. [cited 2020 Aug 07]. Available from: http://digital.library.temple.edu/u?/p245801coll10,179025.

Council of Science Editors:

Wang Z. IMPACT OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2/ABCC2) AND 3 (MRP3/ABCC3) ON THE PHARMACOKINETICS OF METHOTREXATE. [Doctoral Dissertation]. Temple University; 2012. Available from: http://digital.library.temple.edu/u?/p245801coll10,179025


Temple University

19. GANTI, VAISHNAVI. A PHARMACOKINETIC BASED STUDY TO BETTER UNDERSTAND THE REPORTED COGNITIVE DEFICITS FOR 5-FLUOROURACIL AND METHOTREXATE IN MALE SWISS-WEBSTER MICE.

Degree: PhD, 2014, Temple University

Pharmaceutical Sciences

Chemotherapy related neurotoxicity is the decrease in cognitive function observed in patients receiving chemotherapy for breast cancer. For cancers with higher survival rates… (more)

Subjects/Keywords: Pharmaceutical sciences;

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

GANTI, V. (2014). A PHARMACOKINETIC BASED STUDY TO BETTER UNDERSTAND THE REPORTED COGNITIVE DEFICITS FOR 5-FLUOROURACIL AND METHOTREXATE IN MALE SWISS-WEBSTER MICE. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,262852

Chicago Manual of Style (16th Edition):

GANTI, VAISHNAVI. “A PHARMACOKINETIC BASED STUDY TO BETTER UNDERSTAND THE REPORTED COGNITIVE DEFICITS FOR 5-FLUOROURACIL AND METHOTREXATE IN MALE SWISS-WEBSTER MICE.” 2014. Doctoral Dissertation, Temple University. Accessed August 07, 2020. http://digital.library.temple.edu/u?/p245801coll10,262852.

MLA Handbook (7th Edition):

GANTI, VAISHNAVI. “A PHARMACOKINETIC BASED STUDY TO BETTER UNDERSTAND THE REPORTED COGNITIVE DEFICITS FOR 5-FLUOROURACIL AND METHOTREXATE IN MALE SWISS-WEBSTER MICE.” 2014. Web. 07 Aug 2020.

Vancouver:

GANTI V. A PHARMACOKINETIC BASED STUDY TO BETTER UNDERSTAND THE REPORTED COGNITIVE DEFICITS FOR 5-FLUOROURACIL AND METHOTREXATE IN MALE SWISS-WEBSTER MICE. [Internet] [Doctoral dissertation]. Temple University; 2014. [cited 2020 Aug 07]. Available from: http://digital.library.temple.edu/u?/p245801coll10,262852.

Council of Science Editors:

GANTI V. A PHARMACOKINETIC BASED STUDY TO BETTER UNDERSTAND THE REPORTED COGNITIVE DEFICITS FOR 5-FLUOROURACIL AND METHOTREXATE IN MALE SWISS-WEBSTER MICE. [Doctoral Dissertation]. Temple University; 2014. Available from: http://digital.library.temple.edu/u?/p245801coll10,262852


University of Alberta

20. Burres, Neal S. The mechanism of action of methotrexate-induced BeWo cell differentiation.

Degree: PhD, Department of Biochemistry, 1985, University of Alberta

Subjects/Keywords: Cell differentiation.; Choriocarcinoma.; Methotrexate.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Burres, N. S. (1985). The mechanism of action of methotrexate-induced BeWo cell differentiation. (Doctoral Dissertation). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/5712m888x

Chicago Manual of Style (16th Edition):

Burres, Neal S. “The mechanism of action of methotrexate-induced BeWo cell differentiation.” 1985. Doctoral Dissertation, University of Alberta. Accessed August 07, 2020. https://era.library.ualberta.ca/files/5712m888x.

MLA Handbook (7th Edition):

Burres, Neal S. “The mechanism of action of methotrexate-induced BeWo cell differentiation.” 1985. Web. 07 Aug 2020.

Vancouver:

Burres NS. The mechanism of action of methotrexate-induced BeWo cell differentiation. [Internet] [Doctoral dissertation]. University of Alberta; 1985. [cited 2020 Aug 07]. Available from: https://era.library.ualberta.ca/files/5712m888x.

Council of Science Editors:

Burres NS. The mechanism of action of methotrexate-induced BeWo cell differentiation. [Doctoral Dissertation]. University of Alberta; 1985. Available from: https://era.library.ualberta.ca/files/5712m888x

21. Atal, Sezen. Erişkin erkek sıçanlarda metotreksat kaynaklı testis hasarında kurkuminin etkisi .

Degree: Histoloji ve Embriyoloji, 2014, Eskisehir Osmangazi University

 Metotreksat, kanser tedavisinde sıklıkla kullanılan kemoterapotik bir maddedir. Ayrıca testis üzerinde de toksik bir etki göstermektedir. Hücre ve dokular, meydana gelen bu toksik etkilerden kurkumin… (more)

Subjects/Keywords: Metotreksat; Kurkumin; Sıçan; Testis; Methotrexate; Curcumin; Rat; Testis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Atal, S. (2014). Erişkin erkek sıçanlarda metotreksat kaynaklı testis hasarında kurkuminin etkisi . (Thesis). Eskisehir Osmangazi University. Retrieved from http://hdl.handle.net/11684/294

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Atal, Sezen. “Erişkin erkek sıçanlarda metotreksat kaynaklı testis hasarında kurkuminin etkisi .” 2014. Thesis, Eskisehir Osmangazi University. Accessed August 07, 2020. http://hdl.handle.net/11684/294.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Atal, Sezen. “Erişkin erkek sıçanlarda metotreksat kaynaklı testis hasarında kurkuminin etkisi .” 2014. Web. 07 Aug 2020.

Vancouver:

Atal S. Erişkin erkek sıçanlarda metotreksat kaynaklı testis hasarında kurkuminin etkisi . [Internet] [Thesis]. Eskisehir Osmangazi University; 2014. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/11684/294.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Atal S. Erişkin erkek sıçanlarda metotreksat kaynaklı testis hasarında kurkuminin etkisi . [Thesis]. Eskisehir Osmangazi University; 2014. Available from: http://hdl.handle.net/11684/294

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


The Ohio State University

22. Fan, Yongjia. Bistability in Human Dihydrofolate Reductase Catalysis.

Degree: MS, Chemical and Biomolecular Engineering, 2010, The Ohio State University

  Bistability is the existence of two stable steady states consistent with the same operating conditions. The mechanism for bistability is generally presumed to lie… (more)

Subjects/Keywords: Chemical Engineering; Bistability; human dihydrofolate reductase; methotrexate; thymidylate synthesis pathway

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fan, Y. (2010). Bistability in Human Dihydrofolate Reductase Catalysis. (Masters Thesis). The Ohio State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=osu1280243471

Chicago Manual of Style (16th Edition):

Fan, Yongjia. “Bistability in Human Dihydrofolate Reductase Catalysis.” 2010. Masters Thesis, The Ohio State University. Accessed August 07, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=osu1280243471.

MLA Handbook (7th Edition):

Fan, Yongjia. “Bistability in Human Dihydrofolate Reductase Catalysis.” 2010. Web. 07 Aug 2020.

Vancouver:

Fan Y. Bistability in Human Dihydrofolate Reductase Catalysis. [Internet] [Masters thesis]. The Ohio State University; 2010. [cited 2020 Aug 07]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1280243471.

Council of Science Editors:

Fan Y. Bistability in Human Dihydrofolate Reductase Catalysis. [Masters Thesis]. The Ohio State University; 2010. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1280243471


University of Otago

23. Korell, Julia. Modelling Red Blood Cell Data .

Degree: 2012, University of Otago

 The overarching aim of this work was to utilise modelling and simulation methodology to obtain a better understanding of clinical data generated from or in… (more)

Subjects/Keywords: lifespan; mathematical model; pharmacometrics; methotrexate; red blood cell; pharmacokinetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Korell, J. (2012). Modelling Red Blood Cell Data . (Doctoral Dissertation). University of Otago. Retrieved from http://hdl.handle.net/10523/2659

Chicago Manual of Style (16th Edition):

Korell, Julia. “Modelling Red Blood Cell Data .” 2012. Doctoral Dissertation, University of Otago. Accessed August 07, 2020. http://hdl.handle.net/10523/2659.

MLA Handbook (7th Edition):

Korell, Julia. “Modelling Red Blood Cell Data .” 2012. Web. 07 Aug 2020.

Vancouver:

Korell J. Modelling Red Blood Cell Data . [Internet] [Doctoral dissertation]. University of Otago; 2012. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10523/2659.

Council of Science Editors:

Korell J. Modelling Red Blood Cell Data . [Doctoral Dissertation]. University of Otago; 2012. Available from: http://hdl.handle.net/10523/2659


University of Otago

24. Pan, Shan. Application of pharmacometric methods to quantify the effects of methotrexate in rheumatoid arthritis .

Degree: University of Otago

 Rheumatoid arthritis (RA) is a common inflammatory disease that affects between 0.5% and 1% of adults in developed countries. It is a chronic and progressive… (more)

Subjects/Keywords: pharmacometrics; methotrexate; rheumatoid; arthritis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pan, S. (n.d.). Application of pharmacometric methods to quantify the effects of methotrexate in rheumatoid arthritis . (Doctoral Dissertation). University of Otago. Retrieved from http://hdl.handle.net/10523/6211

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Chicago Manual of Style (16th Edition):

Pan, Shan. “Application of pharmacometric methods to quantify the effects of methotrexate in rheumatoid arthritis .” Doctoral Dissertation, University of Otago. Accessed August 07, 2020. http://hdl.handle.net/10523/6211.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

MLA Handbook (7th Edition):

Pan, Shan. “Application of pharmacometric methods to quantify the effects of methotrexate in rheumatoid arthritis .” Web. 07 Aug 2020.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Pan S. Application of pharmacometric methods to quantify the effects of methotrexate in rheumatoid arthritis . [Internet] [Doctoral dissertation]. University of Otago; [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10523/6211.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Council of Science Editors:

Pan S. Application of pharmacometric methods to quantify the effects of methotrexate in rheumatoid arthritis . [Doctoral Dissertation]. University of Otago; Available from: http://hdl.handle.net/10523/6211

Note: this citation may be lacking information needed for this citation format:
No year of publication.


University of Wollongong

25. Oktaria, Sianne. Advances in targeted radiosensitiser and nanotherapeutic agents for cancer therapy.

Degree: PhD, 2014, University of Wollongong

  Although the treatment of cancer continues to improve, the treatment of highgrade gliomas remains a major challenge; current treatments are palliative rather than curative.… (more)

Subjects/Keywords: radiosensitise; high-z; bromodeoxyuridine; methotrexate; nanoparticles; in vitro

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Oktaria, S. (2014). Advances in targeted radiosensitiser and nanotherapeutic agents for cancer therapy. (Doctoral Dissertation). University of Wollongong. Retrieved from 0299 OTHER PHYSICAL SCIENCES ; https://ro.uow.edu.au/theses/4268

Chicago Manual of Style (16th Edition):

Oktaria, Sianne. “Advances in targeted radiosensitiser and nanotherapeutic agents for cancer therapy.” 2014. Doctoral Dissertation, University of Wollongong. Accessed August 07, 2020. 0299 OTHER PHYSICAL SCIENCES ; https://ro.uow.edu.au/theses/4268.

MLA Handbook (7th Edition):

Oktaria, Sianne. “Advances in targeted radiosensitiser and nanotherapeutic agents for cancer therapy.” 2014. Web. 07 Aug 2020.

Vancouver:

Oktaria S. Advances in targeted radiosensitiser and nanotherapeutic agents for cancer therapy. [Internet] [Doctoral dissertation]. University of Wollongong; 2014. [cited 2020 Aug 07]. Available from: 0299 OTHER PHYSICAL SCIENCES ; https://ro.uow.edu.au/theses/4268.

Council of Science Editors:

Oktaria S. Advances in targeted radiosensitiser and nanotherapeutic agents for cancer therapy. [Doctoral Dissertation]. University of Wollongong; 2014. Available from: 0299 OTHER PHYSICAL SCIENCES ; https://ro.uow.edu.au/theses/4268


University of Adelaide

26. Fan, Chiaming. Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid.

Degree: 2011, University of Adelaide

 During childhood and adolescence, bone continues to lengthen through endochondral ossification, which occurs within the growth plate and the adjacent metaphysis. As the production of… (more)

Subjects/Keywords: methotrexate; chemotherapy; folinic acid; bone growth; growth plate; bone loss

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fan, C. (2011). Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/69314

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fan, Chiaming. “Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid.” 2011. Thesis, University of Adelaide. Accessed August 07, 2020. http://hdl.handle.net/2440/69314.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fan, Chiaming. “Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid.” 2011. Web. 07 Aug 2020.

Vancouver:

Fan C. Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid. [Internet] [Thesis]. University of Adelaide; 2011. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2440/69314.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fan C. Prevention of methotrexate chemotherapy-induced bone growth arrest and osteoporosis with folinic acid. [Thesis]. University of Adelaide; 2011. Available from: http://hdl.handle.net/2440/69314

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Univerzitet u Beogradu

27. Vejnović, Dubravka T. Povezanost polimorfizama gena koji kodiraju enzime folatnog ciklusa sa efikasnošću i toksičnošću metotreksata kod pacijenata sa reumatoidnim artritisom.

Degree: Biološki fakultet, 2017, Univerzitet u Beogradu

humana genetika - farmakogenetika / human genetics - pharmacogenetics

Reumatoidni artritis (RA) je hronična autoimuna bolest koju karakteriše hronično zapaljenje, oštećenje zglobova i bol. Najčešće… (more)

Subjects/Keywords: rheumatoid arthritis; methotrexate; gene polymorphisms; efficacy; adverse drug effects

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vejnović, D. T. (2017). Povezanost polimorfizama gena koji kodiraju enzime folatnog ciklusa sa efikasnošću i toksičnošću metotreksata kod pacijenata sa reumatoidnim artritisom. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:15996/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Vejnović, Dubravka T. “Povezanost polimorfizama gena koji kodiraju enzime folatnog ciklusa sa efikasnošću i toksičnošću metotreksata kod pacijenata sa reumatoidnim artritisom.” 2017. Thesis, Univerzitet u Beogradu. Accessed August 07, 2020. https://fedorabg.bg.ac.rs/fedora/get/o:15996/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Vejnović, Dubravka T. “Povezanost polimorfizama gena koji kodiraju enzime folatnog ciklusa sa efikasnošću i toksičnošću metotreksata kod pacijenata sa reumatoidnim artritisom.” 2017. Web. 07 Aug 2020.

Vancouver:

Vejnović DT. Povezanost polimorfizama gena koji kodiraju enzime folatnog ciklusa sa efikasnošću i toksičnošću metotreksata kod pacijenata sa reumatoidnim artritisom. [Internet] [Thesis]. Univerzitet u Beogradu; 2017. [cited 2020 Aug 07]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:15996/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Vejnović DT. Povezanost polimorfizama gena koji kodiraju enzime folatnog ciklusa sa efikasnošću i toksičnošću metotreksata kod pacijenata sa reumatoidnim artritisom. [Thesis]. Univerzitet u Beogradu; 2017. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:15996/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Boston University

28. Farooq, Jeffrey. Efficacy of pharmacological agents on the remission induction and maintenance of Crohn's disease.

Degree: MS, Medical Sciences, 2019, Boston University

 The two options for treatment of the inflammatory bowel disease Crohn’s Disease are surgery and pharmacotherapy. Pharmacotherapy with the goal of inducing and maintaining remission… (more)

Subjects/Keywords: Medicine; Biologics; Corticosteroids; Crohn's disease; Inflammatory bowel disease; Methotrexate; Thiopurines

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Farooq, J. (2019). Efficacy of pharmacological agents on the remission induction and maintenance of Crohn's disease. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/36543

Chicago Manual of Style (16th Edition):

Farooq, Jeffrey. “Efficacy of pharmacological agents on the remission induction and maintenance of Crohn's disease.” 2019. Masters Thesis, Boston University. Accessed August 07, 2020. http://hdl.handle.net/2144/36543.

MLA Handbook (7th Edition):

Farooq, Jeffrey. “Efficacy of pharmacological agents on the remission induction and maintenance of Crohn's disease.” 2019. Web. 07 Aug 2020.

Vancouver:

Farooq J. Efficacy of pharmacological agents on the remission induction and maintenance of Crohn's disease. [Internet] [Masters thesis]. Boston University; 2019. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2144/36543.

Council of Science Editors:

Farooq J. Efficacy of pharmacological agents on the remission induction and maintenance of Crohn's disease. [Masters Thesis]. Boston University; 2019. Available from: http://hdl.handle.net/2144/36543


University of Cincinnati

29. Manna, Soumyarwit. Sustained Release Micro-implants for Delivery of Hydrophilic Drugs to Treat Vitreoretinal Diseases.

Degree: PhD, Engineering and Applied Science: Materials Science, 2016, University of Cincinnati

 A drug delivery device (micro-implant) providing sustained release of <i> hydrophilic </i> drugs has the potential to improve the therapeutic outcome for treatment of vitreoretinal… (more)

Subjects/Keywords: Materials Science; Vitreoretinal; Chitosan; Methotrexate; Polylactic acid; Implant; Drug delivery

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Manna, S. (2016). Sustained Release Micro-implants for Delivery of Hydrophilic Drugs to Treat Vitreoretinal Diseases. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1471346005

Chicago Manual of Style (16th Edition):

Manna, Soumyarwit. “Sustained Release Micro-implants for Delivery of Hydrophilic Drugs to Treat Vitreoretinal Diseases.” 2016. Doctoral Dissertation, University of Cincinnati. Accessed August 07, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1471346005.

MLA Handbook (7th Edition):

Manna, Soumyarwit. “Sustained Release Micro-implants for Delivery of Hydrophilic Drugs to Treat Vitreoretinal Diseases.” 2016. Web. 07 Aug 2020.

Vancouver:

Manna S. Sustained Release Micro-implants for Delivery of Hydrophilic Drugs to Treat Vitreoretinal Diseases. [Internet] [Doctoral dissertation]. University of Cincinnati; 2016. [cited 2020 Aug 07]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1471346005.

Council of Science Editors:

Manna S. Sustained Release Micro-implants for Delivery of Hydrophilic Drugs to Treat Vitreoretinal Diseases. [Doctoral Dissertation]. University of Cincinnati; 2016. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1471346005


University of Aberdeen

30. Prise, Kevin M. Cell death and DNA damage in methotrexate-treated HeLa cells.

Degree: PhD, 1985, University of Aberdeen

 The cancer chemotherapeutic agent methotrexate inhibits the enzyme dihydrofolate reductase leading to a depletion of cellular reduced folates and inhibition of thymidylate synthase. A predicted… (more)

Subjects/Keywords: 572.8; Methotrexate-treated cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Prise, K. M. (1985). Cell death and DNA damage in methotrexate-treated HeLa cells. (Doctoral Dissertation). University of Aberdeen. Retrieved from http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU362655 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378094

Chicago Manual of Style (16th Edition):

Prise, Kevin M. “Cell death and DNA damage in methotrexate-treated HeLa cells.” 1985. Doctoral Dissertation, University of Aberdeen. Accessed August 07, 2020. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU362655 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378094.

MLA Handbook (7th Edition):

Prise, Kevin M. “Cell death and DNA damage in methotrexate-treated HeLa cells.” 1985. Web. 07 Aug 2020.

Vancouver:

Prise KM. Cell death and DNA damage in methotrexate-treated HeLa cells. [Internet] [Doctoral dissertation]. University of Aberdeen; 1985. [cited 2020 Aug 07]. Available from: http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU362655 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378094.

Council of Science Editors:

Prise KM. Cell death and DNA damage in methotrexate-treated HeLa cells. [Doctoral Dissertation]. University of Aberdeen; 1985. Available from: http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU362655 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378094

[1] [2] [3] [4] [5]

.